Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.

Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1268-75. doi: 10.1164/rccm.200710-1458OC. Epub 2008 Feb 28.

PMID:
18310479
2.

Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients.

Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y.

J Heart Lung Transplant. 2009 Oct;28(10):1081-6. doi: 10.1016/j.healun.2009.06.005.

PMID:
19782291
3.

Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.

Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, Yamada M, Suzuki S, Yanai M, Kurosawa S, Yamaya M, Kubo H.

Thorax. 2012 Dec;67(12):1067-74. doi: 10.1136/thoraxjnl-2011-201395. Epub 2012 Jul 27.

PMID:
22843558
4.

Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H.

J Am Coll Cardiol. 2005 May 17;45(10):1622-30.

5.

Elevation of circulating endothelial microparticles in patients with chronic renal failure.

Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F.

J Thromb Haemost. 2006 Mar;4(3):566-73. Epub 2005 Dec 23.

6.

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.

Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM.

J Am Soc Nephrol. 2005 Nov;16(11):3381-8. Epub 2005 Sep 28.

7.

Diagnostic role of endothelial microparticles in vasculitis.

Erdbruegger U, Grossheim M, Hertel B, Wyss K, Kirsch T, Woywodt A, Haller H, Haubitz M.

Rheumatology (Oxford). 2008 Dec;47(12):1820-5. doi: 10.1093/rheumatology/ken373. Epub 2008 Oct 16.

PMID:
18927191
8.

Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension.

Reesink HJ, Meijer RC, Lutter R, Boomsma F, Jansen HM, Kloek JJ, Bresser P.

Circ J. 2006 Aug;70(8):1058-63.

9.

Plasma levels of thrombomodulin in pulmonary hypertension.

Cacoub P, Karmochkine M, Dorent R, Nataf P, Piette JC, Godeau P, Gandjbakhch I, Boffa MC.

Am J Med. 1996 Aug;101(2):160-4.

PMID:
8757355
10.

Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects.

Wang JM, Huang YJ, Wang Y, Xu MG, Wang LC, Wang SM, Tao J.

Am J Hypertens. 2007 Sep;20(9):957-64.

PMID:
17765136
11.

Increased production of leukocyte microparticles with enhanced expression of adhesion molecules from activated polymorphonuclear leukocytes in severely injured patients.

Fujimi S, Ogura H, Tanaka H, Koh T, Hosotsubo H, Nakamori Y, Kuwagata Y, Shimazu T, Sugimoto H.

J Trauma. 2003 Jan;54(1):114-9; discussion 119-20.

PMID:
12544906
12.

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.

Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk HM, ten Cate H, Leyte A, Terpstra WE, Falanga A.

Haematologica. 2009 Jul;94(7):911-8. doi: 10.3324/haematol.13774. Epub 2009 Jun 8.

13.

Increased plasma levels of adrenomedullin in patients with pulmonary hypertension.

Kakishita M, Nishikimi T, Okano Y, Satoh T, Kyotani S, Nagaya N, Fukushima K, Nakanishi N, Takishita S, Miyata A, Kangawa K, Matsuo H, Kunieda T.

Clin Sci (Lond). 1999 Jan;96(1):33-9.

PMID:
9857104
14.

Elevated concentration of soluble vascular endothelial cadherin is associated with coronary atherosclerosis.

Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N.

Circ J. 2004 Jan;68(1):1-5.

15.

Metalloproteinase-9 in circulating monocytes in pulmonary hypertension.

Cantini-Salignac C, Lartaud I, Schrijen F, Atkinson J, Chabot F.

Fundam Clin Pharmacol. 2006 Aug;20(4):405-10.

PMID:
16867026
16.

Circulating endothelial microparticle levels and hemodynamic severity of pulmonary hypertension: is there a role for sleep apnea?

Akinnusi ME, El Solh AA.

Am J Respir Crit Care Med. 2009 Feb 15;179(4):328; author reply 328-9. No abstract available.

PMID:
19201930
17.

Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo.

Abid Hussein MN, Meesters EW, Osmanovic N, Romijn FP, Nieuwland R, Sturk A.

J Thromb Haemost. 2003 Nov;1(11):2434-43.

18.

Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension.

González-Quintero VH, Smarkusky LP, Jiménez JJ, Mauro LM, Jy W, Hortsman LL, O'Sullivan MJ, Ahn YS.

Am J Obstet Gynecol. 2004 Oct;191(4):1418-24.

PMID:
15507976
19.

Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis.

Fujimi S, Ogura H, Tanaka H, Koh T, Hosotsubo H, Nakamori Y, Kuwagata Y, Shimazu T, Sugimoto H.

J Trauma. 2002 Mar;52(3):443-8.

PMID:
11901317
20.

Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.

Ederhy S, Di Angelantonio E, Mallat Z, Hugel B, Janower S, Meuleman C, Boccara F, Freyssinet JM, Tedgui A, Cohen A.

Am J Cardiol. 2007 Sep 15;100(6):989-94. Epub 2007 Jul 2.

PMID:
17826384

Supplemental Content

Support Center